Direxion Daily S&P Biotech Bull 3x Shares(LABU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LABU Direxion Daily S&P Biotech Bull 3x Shares

Post-Mkt 06-08 19:46:22 EDT

159.15

-1.11

-0.69%

盘后159.00

-0.15-0.09%

19:41 EDT

High168.87	Low157.00	Vol599.24K
Open166.66	D1 Closing160.26	Amplitude7.40%
Mkt Cap481.35M	Tradable Cap481.35M	Total Shares3.02M
T/O96.70M	T/O Rate19.81%	Tradable Shares3.02M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":159.15,"timestamp":1780948800000,"preClose":160.26,"halted":0,"volume":599243,"hourTrading":{"tag":"盘后","latestPrice":159,"preClose":159.15,"latestTime":"19:41 EDT","volume":1409,"amount":223733.68691000002,"timestamp":1780962115301,"change":-0.15,"changeRate":-0.000943,"amplitude":0.009111},"delay":0,"changeRate":-0.006926244852115221,"floatShares":3024500,"shares":3024500,"eps":0,"marketStatus":"Post-Mkt","change":-1.11,"latestTime":"06-08 19:46:22 EDT","open":166.66,"high":168.8651,"low":157,"amount":96703911.76997,"amplitude":0.074037,"askPrice":160.8,"askSize":200,"bidPrice":157.45,"bidSize":10,"shortable":0,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1780963200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":160.26,"sharesOutstanding":3074486,"nav":160.21,"aum":460522659.34,"dividendRate":0.007754,"bidAskSpread":0.00198,"preHourTrading":{"tag":"盘前","latestPrice":166.8,"preClose":160.26,"latestTime":"09:29 EDT","volume":6027,"amount":998785.15842,"timestamp":1780925378606,"change":6.54,"changeRate":0.040809,"amplitude":0.060402},"postHourTrading":{"tag":"盘后","latestPrice":159,"preClose":159.15,"latestTime":"19:41 EDT","volume":1409,"amount":223733.68691000002,"timestamp":1780962115301,"change":-0.15,"changeRate":-0.000943,"amplitude":0.009111},"volumeRatio":0.721672,"impliedVol":0.9053,"impliedVolPercentile":0.6972},"requestUrl":"/m/hq/s/LABU/wiki","defaultTab":"wiki","newsList":[{"id":"2642371644","title":"Ryman Healthcare outlines terms of new NZX-listed bond offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642371644","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642371644?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:56","pubTimestamp":1780959365,"startTime":"0","endTime":"0","summary":"Ryman Healthcare ( ($NZ:RYM) ) has issued an update. Ryman Healthcare has released a bond presentation outlining an offer of new bonds that will ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ryman-healthcare-outlines-terms-of-new-nzx-listed-bond-offer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ryman-healthcare-outlines-terms-of-new-nzx-listed-bond-offer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["T10G.NZ","FNZ.NZ","NZT.NZ","BK8050","NZ20C.NZ","RYM.NZ","TNZ.NZ","NZX.NZ","XBI","BK4581","BNDW","XLV","BK4585","BK8020","NZ50G.NZ","NZG.NZ","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642443718","title":"Ryman Healthcare Seeks Up to NZ$150m in New 2032 Bond Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2642443718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642443718?lang=en_us&edition=fundamental","pubTime":"2026-06-09 06:55","pubTimestamp":1780959354,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Ryman Healthcare ( ($NZ:RYM) ). Ryman Healthcare is a major operator in the retirement and aged-care sector, us...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ryman-healthcare-seeks-up-to-nz150m-in-new-2032-bond-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ryman-healthcare-seeks-up-to-nz150m-in-new-2032-bond-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","US5Y.BOND","US12M.BOND","US7Y.BOND","US10Y.BOND","TMF","US30Y.BOND","US3Y.BOND","LABU","BK4588","BK4585","RYM.NZ","XBI","US6M.BOND","TLTW","BK8050","XLV","TLT","US2Y.BOND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642432912","title":"Ryman Healthcare Launches NZ$100 Million Six-Year Retail Bond Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2642432912","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642432912?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:55","pubTimestamp":1780955740,"startTime":"0","endTime":"0","summary":"Ryman Healthcare  launched an offer for up to NZ$100 million of six-year fixed-rate secured unsubordinated bonds maturing on June 22, 2032, with the potential to accept up to NZ$50 million in oversubscriptions, according to a Monday filing with the New Zealand bourse.The offer carries an indicative margin of 1.8% to 1.9% above the swap rate, subject to a minimum 5.6% annual interest rate, with final pricing to be set on Thursday after a bookbuild process, per the filing.The new bonds are expected to be listed on the New Zealand Exchange debt market under the ticker \"RYM020\" following their issue on June 22, the filing said.Existing holders of RYM010 bonds may be eligible to exchange their holdings into the new bonds on a one-for-one basis through an optional exchange mechanism, subject to allocation and agreement.Proceeds will be used for debt repayment, refinancing of the RYM010 bonds, and general corporate purposes, a separate filing showed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["US3Y.BOND","XBI","US5Y.BOND","US30Y.BOND","TMF","US6M.BOND","BK7113","TLT","BK4588","RYM.NZ","XLV","BK4581","TLTW","US7Y.BOND","US2Y.BOND","BK4585","RYM.AU","US12M.BOND","US10Y.BOND","LABU","BK8050"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642043268","title":"Alvotech Wins FDA Review for Entyvio Biosimilar AVT16 as Q1 2026 Results Filed","url":"https://stock-news.laohu8.com/highlight/detail?id=2642043268","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642043268?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:29","pubTimestamp":1780954151,"startTime":"0","endTime":"0","summary":"Alvotech ( ($ALVO) ) has provided an update. Alvotech, a specialist in biosimilar development and manufacturing with a growing portfolio of approve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alvotech-wins-fda-review-for-entyvio-biosimilar-avt16-as-q1-2026-results-filed?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alvotech-wins-fda-review-for-entyvio-biosimilar-avt16-as-q1-2026-results-filed?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","ALVO","BK4139","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642434179","title":"Health Care Ticks Down Amid Deal Activity - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2642434179","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642434179?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:00","pubTimestamp":1780952400,"startTime":"0","endTime":"0","summary":"Health-care companies ticked down as deal activity offset fears about generic competition for one key category of drugs.Incyte agreed to buy closely held biotech rival Vega Therapeutics for up to $2 billion, in a deal that would see Incyte acquiring drugs for bleeding disorders.Johnson & Johnson agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that boosts the health-care conglomerate's oncology-drug pipeline.Eli Lilly shares rose after a late-stage trial showed its drug was effective in weight loss and in alleviating obesity-linked conditions. Danish rival Novo Nordisk said prescriptions for its Wegovy weight-loss pill have surpassed three million since launching in early January. Despite the blockbuster sales data, shares of Novo fell sharply, reflecting investors' lofty expectations for GLP-1 drugs. Separately, analysts at brokerage Morgan Stanley warned that Novo Nordisk could soon face stiff generic competition for its Ozempic drug in several key glo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","LU1720051108.HKD","LU0795875086.SGD","LU1162221912.USD","LU2357305700.SGD","XBI","LU0390134368.USD","LU1989772840.SGD","LU0882574139.USD","LU0098860793.USD","LU0225283273.USD","LU1244550494.USD","LU0106261372.USD","LU1548497426.USD","LU1732799900.SGD","LU1363072403.SGD","LU2347655156.SGD","LU2111349929.HKD","LU0053666078.USD","LU0320765646.SGD","LU2023251221.USD","LU2089284900.SGD","IE00BZ1G4Q59.USD","LU0106831901.USD","LU0314104364.USD","LU0912757837.SGD","LU1668664300.SGD","BK4127","LU2089283258.USD","LABU","LU1988902786.USD","LU0210528500.USD","BK4516","BK4585","LU0006306889.USD","LU1791710400.SGD","LU2133065610.SGD","LU1074936037.SGD","LU1064131342.USD","LU2028103732.USD","LU0971096721.USD","LU0158827948.USD","LU0795875169.SGD","XLV","LU0267386448.USD","LU1989772923.USD","LU0557290698.USD","LU0158827781.USD","LU1244550221.USD","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642341704","title":"Evolus (EOLS) Receives a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2642341704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642341704?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:55","pubTimestamp":1780952116,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on Evolus today and set a price target of $15.00. Ear covers the Healthcare sector, focusi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evolus-eols-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evolus-eols-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","BK4588","EOLS","XBI","BK4207","BK4585","MFG","BK4007","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431190","title":"Mineralys Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431190","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431190?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:05","pubTimestamp":1780949100,"startTime":"0","endTime":"0","summary":"RADNOR, Pa., June  08, 2026  (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbiditi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3308453/0/en/Mineralys-Therapeutics-to-Participate-in-the-Goldman-Sachs-47th-Annual-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134796.USD","IE0002270589.USD","LU0128526141.USD","LU1791807156.HKD","XLV","IE00B19Z3581.USD","LU1868836914.USD","LU0742534661.SGD","LU1868836757.USD","LU0345770993.USD","LU0061475181.USD","HCSG","BK4581","BK4550","LU2471134879.HKD","LU1868837300.USD","BK4533","LU2750360997.AUD","MLYS","LU1868837136.USD","GSX","LU0868494708.USD","IE00B19Z3B42.SGD","LU2750360641.GBP","LU2237443978.SGD","XBI","LU0251142724.SGD","LU2265009873.SGD","LU2237443622.USD","BK4516","BK4539","BK4585","LU0096364046.USD","LU2237443549.SGD","LU2471134952.CNY","IE0004086264.USD","BK4552","LU0048573561.USD","LABU","LU2237438978.USD","BK4127","IE0034235188.USD","LU1894683264.USD","LENZ","LU2237443895.HKD","LU2471134523.USD","LU1804176565.USD","LU1894683348.USD","LU0942090050.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431420","title":"Fidia Publishes Governance Slates Ahead of June Shareholders’ Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431420?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:04","pubTimestamp":1780949057,"startTime":"0","endTime":"0","summary":"Fidia Spa ( ($IT:FDA) ) has shared an update. Fidia S.p.A., a Turin-based provider of advanced numerical controls and high-performance integrated m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fidia-publishes-governance-slates-ahead-of-june-shareholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fidia-publishes-governance-slates-ahead-of-june-shareholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VGT","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642439504","title":"Cross Country Healthcare Is Maintained at Market Perform by Barrington Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2642439504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642439504?lang=en_us&edition=fundamental","pubTime":"2026-06-09 03:21","pubTimestamp":1780946460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CCRN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 08, 2026 15:21 ET (19:21 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","LABU","BK4588","XBI","BK4196","BK4585","CCRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642436001","title":"Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2642436001","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642436001?lang=en_us&edition=fundamental","pubTime":"2026-06-09 02:45","pubTimestamp":1780944300,"startTime":"0","endTime":"0","summary":"Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant u","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3308406/0/en/Oculis-to-Present-at-the-47th-Annual-Goldman-Sachs-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360997.AUD","XBI","LU0106831901.USD","LU0345770993.USD","LU2357305700.SGD","LU2237443382.USD","BK4137","LU0029874061.USD","BK4550","LU1854103824.USD","LU1861214812.USD","IE0004086264.USD","LU1861219969.SGD","LU1791807156.HKD","BK4552","LU2237443465.HKD","LU0348723411.USD","LU2237443978.SGD","LU2471134523.USD","LU1720051017.SGD","EMA","LU0868494708.USD","LU1861220033.SGD","ON","GSX","XLV","BK4581","IE00BSNM7G36.USD","IE0004091025.USD","LU2237443549.SGD","LU1868837136.USD","LU1978683503.SGD","BK4141","LU0048573561.USD","LU0128526141.USD","LU0345770308.USD","OCS","BK4585","HCSG","LU1868836591.USD","LU1804176565.USD","LU1668664300.SGD","LU0096364046.USD","IE00BD6J9T35.USD","LU2471134879.HKD","LABU","IE00BFXG1179.USD","LU1868837300.USD","IE0034235188.USD","LU1868836757.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642361334","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Nurix Therapeutics (NRIX) and Incyte (INCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642361334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642361334?lang=en_us&edition=fundamental","pubTime":"2026-06-09 02:10","pubTimestamp":1780942220,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nurix Therapeutics (NRIX) and Incyte (INCY). Nurix Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-nurix-therapeutics-nrix-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-nurix-therapeutics-nrix-and-incyte-incy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","NRIX","LU0128526141.USD","XLV","BK4532","LU0029874061.USD","XBI","INCY","BK4139","BK4585","HCSG","BK4581","BK4550","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642435726","title":"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Ovid Therapeutics (OVID) and Establishment Labs Holdings (ESTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642435726","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642435726?lang=en_us&edition=fundamental","pubTime":"2026-06-09 01:30","pubTimestamp":1780939810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Voyager Therapeutics (VYGR), Ovid Therapeutics (OVID...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-ovid-therapeutics-ovid-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-ovid-therapeutics-ovid-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4137","ESTA","LU0128526141.USD","BK4581","HCSG","LU0029874061.USD","OVID","XLV","VYGR","BK4585","XBI","BK4139","BK4198","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642435800","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2642435800","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642435800?lang=en_us&edition=fundamental","pubTime":"2026-06-09 00:51","pubTimestamp":1780937471,"startTime":"0","endTime":"0","summary":"Healthcare stocks eased Monday afternoon, with the NYSE Healthcare Index down 0.3% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.1%.The iShares Biotechnology ETF  was down 0.7%.In corporate news, Eli Lilly  shares rose 2.4% after the drugmaker said its experimental obesity drug retatrutide delivered significant weight loss in two clinical studies and showed \"meaningful\" improvements in knee osteoarthritis pain and sleep apnea.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1868837300.USD","LU1035775433.USD","IE00BN29S564.USD","LU0882574055.USD","LU0029874061.USD","LU0266013472.USD","LU2746668461.USD","LU2756315318.SGD","LU0689472784.USD","LU1974910355.USD","SG9999015978.USD","LU1069344957.HKD","LU0354030511.USD","LU1057294990.SGD","LU2896262040.SGD","SGXZ51526630.SGD","LU0353189763.USD","LU2491049909.HKD","LU2756315664.SGD","BK4007","LU0198837287.USD","LU2087625088.SGD","LU1267930730.SGD","IE0005OL40V9.USD","IE0009355771.USD","LU1366192091.USD","LU0672654240.SGD","LU2237443549.SGD","LU0158827781.USD","LU0823416689.USD","LU2023250330.USD","SG9999015986.USD","LU1868837136.USD","LU1232071149.USD","SG9999001176.SGD","SG9999014880.SGD","LU0640476718.USD","IE00BJT1NW94.SGD","IE00BFSS8Q28.SGD","LU2168564495.EUR","ELIS","SGXZ99366536.SGD","LU0943347566.SGD","BK4137","LU2112291526.USD","LU2417539215.USD","LU0114720955.EUR","LU0820561909.HKD","LU0320765059.SGD","IE00B775H168.HKD","LU0417517546.SGD","LU0786609619.USD","SG9999018857.SGD","LU1629891620.HKD","LU1983299246.USD","LU2468319806.SGD","LU0256863811.USD","LU2552382058.USD","LU0471298694.HKD","LU0058720904.USD","LU0203201768.USD","LU0096364046.USD","SGXZ81514606.USD","LU0133085943.USD","BK4516","LU1127390331.HKD","IE00B2B36J28.USD","LU2168564065.EUR","LU2357305700.SGD","LU2471134952.CNY","IE00BJJMRZ35.SGD","LU1917777945.USD","LU1804176565.USD","LU2023251221.USD","LU0385154629.USD","LU1551013342.USD","LU2360106947.USD","XLV","LU1551013425.SGD","IE00B1XK9C88.USD","IE0001KFT4U8.USD","LU0122379950.USD","LU2028103732.USD","IE0004445239.USD","SG9999015945.SGD","SG9999015952.SGD","LU1323610961.USD","LLII","LU1093756168.USD","LLYX","LU1064131342.USD","LU2461242641.AUD","IE00BK4W5L77.USD","LU1548497426.USD","LU0823434740.USD","LU0106261372.USD","LU1868836591.USD","LU0882574139.USD","IE00BFSS7M15.SGD","LU2089284900.SGD","IE00BKDWB100.SGD","LU2237443978.SGD","LU2462157665.USD","LU1988902786.USD","LU0128526141.USD","LU0708995401.HKD","LU0787776722.HKD","BK4599","IE0002141913.USD","IE00BKPKM429.USD","IE00BJJMRX11.SGD","SGXZ31699556.SGD","IE00BFTCPJ56.SGD","XBI","LU2750360641.GBP","LU2361044865.SGD","LU0097036916.USD","SGXZ57979304.SGD","LU1061106388.HKD","LU0256863902.USD","LU0225283273.USD","LU2111349929.HKD","LABU","BK4585","LU2552382215.SGD","LU0354030438.USD","SG9999001176.USD","LU1868836914.USD","LLYZ","LU0889565916.HKD","IE00BJLML261.HKD","BK4588","LU2471134523.USD","LU1280957306.USD","LLY","LU2471134879.HKD","LU1720051017.SGD","SG9999014914.USD","LU2324357040.USD","LU0316494557.USD","LU2023250504.SGD","LU0289739699.SGD","LU1989771016.USD","LU2265009873.SGD","BK4533","LU0353189680.USD","LU1623119135.USD","LU0061475181.USD","LU2471134796.USD","ELIL","IE0004445015.USD","LU2211815571.USD","LU1145028129.USD","LU0320765992.SGD","LU2089283258.USD","LU2063271972.USD","LU0471298777.SGD","HCSG","IE00B7KXQ091.USD","LU2271345857.HKD","LU2168564222.USD","SG9999013999.USD","LU2089984988.USD","LU2237443465.HKD","LU2361045086.USD","IE00B4R5TH58.HKD","LU0432979614.USD","LU2237443895.HKD","LU2237443382.USD","LU1814569148.SGD","IE00B1BXHZ80.USD","LU2108987350.USD","LU2361044949.HKD","LU2168563687.JPY","LU0820562030.AUD","LU1023059063.AUD","SG9999018865.SGD","LU2750360997.AUD","LU0823434583.USD","BK4534","LU0323591593.USD","LU0203202063.USD","LU0238689110.USD","LU0158827948.USD","LU2264538146.SGD","LU2491050071.SGD","LU0109394709.USD","BK4581","SG9999014906.USD","LU2236285917.USD","LU2552382132.HKD","LU2491050154.USD","LU0683600562.USD","LU0456855351.SGD","LU2602419157.SGD","SG9999014898.SGD","LU0234572021.USD","LU1093756325.SGD","LU2168564149.EUR","LU0079474960.USD","LU0109391861.USD","LU0006306889.USD","IE00BWXC8680.SGD","IBB","IE00B4JS1V06.HKD","LU2746668974.SGD","IE00BJJMRY28.SGD","LU0094547139.USD","LU1291159041.SGD","IE00BK4W5M84.HKD","LU0820561818.USD","LU2237438978.USD","LU0466842654.USD","LU2106854487.HKD","SG9999017495.SGD","LU1712237335.SGD","GB00BDT5M118.USD","LU2237443622.USD","LU1868836757.USD","LU2456880835.USD","LU2213496289.HKD","LU1720051108.HKD","LU0210536198.USD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642058433","title":"Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immunotherapeutics (MLTX) and MBX Biosciences, Inc. (MBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642058433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642058433?lang=en_us&edition=fundamental","pubTime":"2026-06-09 00:40","pubTimestamp":1780936810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immuno...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-moonlake-immunotherapeutics-mltx-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-artiva-biotherapeutics-inc-artv-moonlake-immunotherapeutics-mltx-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTV","MLTX","BK4137","LU0029874061.USD","BK4139","BK4581","LABU","BK4588","LU0128526141.USD","MBX","BK4585","BK4007","HCSG","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641438058","title":"Ram Selvaraju Reiterates Buy on ProMIS Neurosciences, Maintains $18 12-Month Price Target on Differentiated PMN310 Alzheimer’s Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2641438058","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641438058?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:35","pubTimestamp":1780932923,"startTime":"0","endTime":"0","summary":"ProMIS Neurosciences, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. Wainwright reite...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ram-selvaraju-reiterates-buy-on-promis-neurosciences-maintains-18-12-month-price-target-on-differentiated-pmn310-alzheimers-profile-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ram-selvaraju-reiterates-buy-on-promis-neurosciences-maintains-18-12-month-price-target-on-differentiated-pmn310-alzheimers-profile-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4588","XBI","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641643803","title":"Ondine Biomedical Expands Equity Incentives Ahead of Key FDA Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2641643803","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641643803?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:27","pubTimestamp":1780932449,"startTime":"0","endTime":"0","summary":"Ondine Biomedical, Inc. ( ($GB:OBI) ) has issued an announcement. Ondine Biomedical has granted 3,121,471 restricted share units to employees and e...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ondine-biomedical-expands-equity-incentives-ahead-of-key-fda-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ondine-biomedical-expands-equity-incentives-ahead-of-key-fda-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","EQR","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641381814","title":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641381814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641381814?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:20","pubTimestamp":1780932007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurogene (NGNE) and Lyell Immunopharma (LYEL) with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-lyell-immunopharma-lyel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-lyell-immunopharma-lyel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","HCSG","LU0029874061.USD","BK4588","LYEL","NGNE","BK4581","BK4585","LABU","XBI","BK4539","XLV","BK4137","LU0128526141.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641480562","title":"Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and CVS Health (CVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641480562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641480562?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:20","pubTimestamp":1780928404,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Senseonics Holdings (SENS) and CVS Health (CVS) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-senseonics-holdings-sens-and-cvs-health-cvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-senseonics-holdings-sens-and-cvs-health-cvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0006061336.USD","LU1983299246.USD","LU1923622614.USD","LU2125909247.SGD","BK4581","BK4504","LU0072461881.USD","LU0208291251.USD","LU2125909593.SGD","IE00B7SZLL34.SGD","LABU","LU2433249047.HKD","LU0061475181.USD","LU1699723380.USD","BK4585","LU0070302665.USD","XLV","LU1571399168.USD","BK4196","BK4082","IE00B19Z3581.USD","BK4588","IE0002270589.USD","LU0029874061.USD","LU0432979614.USD","IE00B19Z3B42.SGD","LU0128526141.USD","BK4550","LU1059921491.USD","IE00BKVL7J92.USD","LU0211331839.USD","CVS","LU0320765489.SGD","IE00BZ1G4Q59.USD","XBI","BK4137","IE00BSNM7G36.USD","HCSG","LU0162691827.USD","SENS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641480837","title":"Incannex Healthcare Initiated at Buy by Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2641480837","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641480837?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:15","pubTimestamp":1780928100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IXHL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 08, 2026 10:15 ET (14:15 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4581","XLV","IXHL","BK4588","BK4137","LU0128526141.USD","LABU","BK4585","HCSG","LU0029874061.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641808584","title":"Dianthus Therapeutics (DNTH) Is Down 10.0% After FDA Eases Claseprubart Trials And Grants Orphan Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2641808584","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641808584?lang=en_us&edition=fundamental","pubTime":"2026-06-08 21:28","pubTimestamp":1780925323,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics recently advanced its pipeline as the FDA eased safety requirements for claseprubart trials and granted the program orphan drug designation, while the company also prioritized its dual-mechanism autoimmune candidate DNTH212 with key clinical milestones scheduled through 2028.\nThese regulatory and clinical developments, coupled with upcoming conference commentary, highlight how streamlined trial execution and targeted rare-disease positioning could reshape perceptions of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dnth/dianthus-therapeutics/news/dianthus-therapeutics-dnth-is-down-100-after-fda-eases-clase","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dnth/dianthus-therapeutics/news/dianthus-therapeutics-dnth-is-down-100-after-fda-eases-clase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","LABU","BK4588","BK4585","DNTH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1794},{"period":"1month","weight":-0.2112},{"period":"3month","weight":0.0113},{"period":"6month","weight":-0.0374},{"period":"1year","weight":1.817},{"period":"ytd","weight":0.0055}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds (\"ETFs\") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (\"GICS\"). The fund is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.020883},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.009536},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.135885},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.001739},{"month":5,"riseRate":0.545455,"avgChangeRate":0.013816},{"month":6,"riseRate":0.666667,"avgChangeRate":0.10234},{"month":7,"riseRate":0.636364,"avgChangeRate":0.054287},{"month":8,"riseRate":0.636364,"avgChangeRate":-0.004065},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.0652},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.047038},{"month":11,"riseRate":0.818182,"avgChangeRate":0.199161},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.032237}],"exchange":"ARCA","name":"Direxion Daily S&P Biotech Bull 3x Shares","nameEN":"Direxion Daily S&P Biotech Bull 3x Shares"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Direxion Daily S&P Biotech Bull 3x Shares(LABU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Direxion Daily S&P Biotech Bull 3x Shares(LABU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Direxion Daily S&P Biotech Bull 3x Shares,LABU,Direxion Daily S&P Biotech Bull 3x Shares股票,Direxion Daily S&P Biotech Bull 3x Shares股票老虎,Direxion Daily S&P Biotech Bull 3x Shares股票老虎国际,Direxion Daily S&P Biotech Bull 3x Shares行情,Direxion Daily S&P Biotech Bull 3x Shares股票行情,Direxion Daily S&P Biotech Bull 3x Shares股价,Direxion Daily S&P Biotech Bull 3x Shares股市,Direxion Daily S&P Biotech Bull 3x Shares股票价格,Direxion Daily S&P Biotech Bull 3x Shares股票交易,Direxion Daily S&P Biotech Bull 3x Shares股票购买,Direxion Daily S&P Biotech Bull 3x Shares股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Direxion Daily S&P Biotech Bull 3x Shares(LABU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Direxion Daily S&P Biotech Bull 3x Shares(LABU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}